One of my favorite life sciences industry media channels, BioPharma Dive, had a story this week about a new collaboration between IBM’s Watson Health division and 14 major oncology centers nationwide. The alliance is focused on bringing unprecedented analytics technology to cancer genomics.
The potential of this kind of collaboration on the growth of precision medicine, and its impact on the oncology market is exciting. Watson isn’t just for beating humans at Jeopardy! It is now a core part of IBMs strategic vision in a number of different markets, including life sciences. Continue reading →